Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)PAFIT-IBDNCT07484620
Physical Activity and Fitness in Pediatric Inflammatory Bowel Disease
A study testing Physical Activity Intervention in people with Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) and Inflamatory Bowel Disease, run by Universidad Complutense de Madrid at 1 site in Spain.
Trial summary
Pediatric inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic condition associated not only with intestinal inflammation but also with reduced physical fitness, fatigue, impaired quality of life, and psychosocial difficulties. Read more about this study
- Who is it for?
- Ages 6 to 17 years
- Conditions the study is for
- Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis), Inflamatory Bowel Disease
- What is being tested?
- Physical Activity Intervention
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteSpain
- Study dates
- 1 Apr 2026to 1 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Children and adolescents aged 6 to 17 years
- Confirmed diagnosis of Crohn's disease or ulcerative colitis
- Clinical remission or mild-to-moderate disease activity
- Medical clearance to participate in physical activity
- Ability to complete study assessments and follow-up procedures
- Written informed consent from a parent or legal guardian and assent from the participant
Who cannot join
- Severe disease activity or acute flare requiring hospitalization
- Medical contraindications to exercise (e.g., severe cardiopulmonary disease, uncontrolled anemia, significant musculoskeletal conditions)
- Major surgery within the previous 3 months
- Participation in another interventional clinical trial
- Cognitive or behavioral conditions preventing participation
- Any condition considered unsafe by the investigators or treating physician
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effects of Physical Activity and Physical Fitness on Inflammation, Clinical Outcomes, and Quality of Life in Pediatric Inflammatory Bowel Disease
Pediatric inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic condition associated not only with intestinal inflammation but also with reduced physical fitness, fatigue, impaired quality of life, and psychosocial difficulties. Although physical activity and physical fitness are recognized as important determinants of health in the general pediatric population, their role as modifiable prognostic factors in children and adolescents with IBD remains insufficiently studied, particularly using objective measures and longitudinal designs in hospital settings.
The present hospital-based study aims to investigate the effects of physical activity and physical fitness on inflammation, clinical outcomes, and quality of life in children and adolescents with IBD. The project comprises three phases: (1) an observational cross-sectional and longitudinal assessment, (2) a randomized controlled trial (RCT) evaluating a structured physical activity intervention, and (3) a medium-term follow-up at 6-12 months.
Read more
Physical activity will be assessed objectively using accelerometry and subjectively using validated questionnaires. Physical fitness will be evaluated with the ALPHA fitness battery adapted to the hospital setting, with cardiorespiratory fitness assessed by the 20-meter shuttle run test as the primary outcome of the RCT. Clinical outcomes will include objective inflammatory markers (fecal calprotectin and C-reactive protein), disease activity indices (PCDAI or PUCAI), musculoskeletal health, fatigue, cognitive functioning, and health-related quality of life. Nutritional status and dietary quality will also be assessed, and selected biological markers will be analyzed in a subsample.
The RCT will examine whether a 12-week supervised physical activity program improves cardiorespiratory fitness compared with usual care, and whether changes in fitness are accompanied by improvements in inflammatory burden and patient-reported outcomes. Longitudinal analyses will explore the sustainability of these effects over time.
This study will provide comprehensive, objective evidence on the role of physical activity and physical fitness as modifiable factors in pediatric IBD. The results are expected to inform clinical practice, support the integration of structured physical activity into multidisciplinary care, and contribute high-quality data for publication in international peer-reviewed journals.
Read the detailed description
Pediatric inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic condition frequently diagnosed during childhood and adolescence. In addition to persistent intestinal inflammation, pediatric IBD is associated with reduced physical activity levels, impaired physical fitness, fatigue, musculoskeletal complaints, cognitive and psychosocial difficulties, and diminished health-related quality of life. Despite advances in pharmacological treatment, many children and adolescents continue to experience functional limitations that are not fully addressed by standard medical care.
Physical activity and physical fitness are modifiable lifestyle factors with well-established benefits in healthy pediatric populations, including anti-inflammatory effects, improved cardiorespiratory and muscular fitness, and better mental health and quality of life. However, in pediatric IBD, evidence remains limited, particularly from studies using objective measurements of physical activity and fitness, randomized controlled designs, and longitudinal follow-up in hospital-based settings. Furthermore, the relationships between physical activity, physical fitness, inflammation, clinical outcomes, and quality of life have not been comprehensively examined within a single integrated study framework.
This hospital-based study aims to evaluate the role of physical activity and physical fitness as modifiable factors influencing inflammation, clinical outcomes, and quality of life in children and adolescents with IBD. The study is conducted in three sequential phases: (1) an observational cross-sectional and longitudinal assessment, (2) a randomized controlled trial (RCT) of a structured physical activity intervention, and (3) a medium-term follow-up at 6 to 12 months.
In the observational phase, participants aged 8 to 17 years with a confirmed diagnosis of Crohn's disease or ulcerative colitis will undergo comprehensive baseline assessments. Physical activity will be measured objectively using accelerometry over seven consecutive days and supplemented by validated questionnaires. Physical fitness will be assessed using the ALPHA fitness battery adapted to the hospital environment, including cardiorespiratory fitness measured by the 20-meter shuttle run test, muscular strength, agility, and body composition. Clinical outcomes will include objective inflammatory markers (fecal calprotectin and C-reactive protein), disease activity indices (PCDAI or PUCAI), musculoskeletal health, fatigue, cognitive functioning, and health-related quality of life. Nutritional status and dietary quality will also be evaluated, and selected biological markers will be analyzed in a subsample.
In the interventional phase, eligible participants will be randomized to either a 12-week structured physical activity program or usual care. The intervention consists of supervised, age-appropriate exercise sessions combining aerobic and strength-based activities, tailored to participants' clinical status and functional capacity. The primary outcome of the RCT is the change in cardiorespiratory fitness, assessed by the number of laps completed in the 20-meter shuttle run test. Secondary outcomes include changes in inflammatory markers, disease activity indices, physical fitness components, fatigue, cognitive performance, nutritional status, and quality of life.
The follow-up phase will assess the sustainability of changes in physical activity, physical fitness, inflammation, and clinical outcomes at 6 to 12 months after baseline assessment or completion of the intervention. Longitudinal analyses will examine whether baseline and intervention-induced changes in physical activity and physical fitness predict medium-term clinical and patient-reported outcomes.
All questionnaires, cognitive assessments, and consent procedures will be administered electronically using secure institutional platforms. Data will be collected and stored in a pseudonymized manner in accordance with applicable data protection regulations.
This study is designed to provide high-quality, objective evidence on the clinical relevance of physical activity and physical fitness in pediatric IBD. By integrating functional, inflammatory, and patient-centered outcomes, the findings are expected to inform multidisciplinary care strategies and support the incorporation of structured physical activity into routine clinical management for children and adolescents with IBD.
- Being tested
- Physical Activity Intervention
- Keywords
- Pediatric Inflammatory Bowel Disease, Health-Related Quality of Life, Fecal Calprotectin, Physical Fitness, Cardiorespiratory Fitness, Accelerometry, Cognitive Function, Disease Activity
- Medical subject headings
- Colitis, Ulcerative
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Physical Activity InterventionOther
Participants will complete a 12-week structured physical activity program consisting of 2-3 supervised sessions per week combining moderate-intensity aerobic exercise and muscle-strengthening activities. The program is age-appropriate, individualized to clinical status and fitness level, and delivered under professional supervision.
| Study group | Role | What they receive |
|---|---|---|
| Physical Activity Intervention | Experimental | Participants will take part in a structured physical activity program lasting 12 weeks. The intervention consists of supervised, age-appropriate exercise sessions combining aerobic and strength-based activities, adapted to each participant's clinical status and functional capacity. All participants receive the same intervention and serve as their own control through pre- and post-intervention assessments. Receives: Other: Physical Activity Intervention |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cardiorespiratory fitness assessed by the 20-meter shuttle run test (20mSRT)
Cardiorespiratory fitness will be assessed using the ALPHA 20-meter shuttle run test (20mSRT). Participants run back and forth between two lines 20 meters apart at increasing speeds guided by audio signals. The outcome is the number of laps completed before exhaustion. Higher values indicate better cardiorespiratory fitness.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Handgrip strength
Upper-limb muscular strength will be assessed using handgrip dynamometry. Participants perform maximal voluntary contractions using a calibrated handgrip dynamometer. The outcome will be expressed in kilograms (kg), with higher values indicating greater muscular strength.
Measured: Baseline (Week 0), post-intervention (Week 12) and follow-up (6-12 months)
Standing Long Jump
Lower-body muscular power will be assessed using the standing long jump test. Participants jump forward as far as possible from a standing position. The outcome will be recorded as the distance jumped in centimeters (cm), with greater distances indicating greater muscular power.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Secondary outcomes (19)
Speed and Agility (4 × 10 m Shuttle Run Test)
Speed and agility will be evaluated using the ALPHA 4 × 10 meter shuttle run test. Participants run back and forth between two lines four times as quickly as possible. The outcome is recorded as the time required to complete the test in seconds. Lower times indicate better performance.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Moderate-to-Vigorous Physical Activity (MVPA)
Moderate-to-vigorous physical activity will be measured objectively using accelerometry worn for 7 consecutive days. The outcome represents the average daily minutes spent in moderate-to-vigorous physical activity according to validated pediatric accelerometer cut-points. Higher values indicate higher levels of moderate-to-vigorous physical activity.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Total Sedentary Time
Total sedentary time will be measured using accelerometry over 7 consecutive days. The outcome represents the average number of minutes per day spent in sedentary behavior according to established accelerometer thresholds. Higher values indicate lower levels of physical activity.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Lean Body Mass
Body composition will be assessed using bioelectrical impedance analysis. The outcome will be lean body mass expressed in kilograms (kg), representing the estimated mass of non-fat tissues. Higher values indicate greater lean mass.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Body Fat Percentage
Body composition will be assessed using bioelectrical impedance analysis. The outcome will be body fat percentage (%), which estimates the proportion of total body mass composed of fat tissue. Scores range from 0 to 100. Higher values indicate greater adiposity.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Body Mass Index (BMI) z-Score
Body mass index (BMI) will be calculated as weight in kilograms divided by height in meters squared (kg/m²). Age- and sex-specific BMI z-scores will be calculated using established pediatric growth reference standards. BMI z-scores provide a standardized measure of relative body mass in children and adolescents. Higher z-score values indicate greater relative body mass for age and sex. In pediatric populations, BMI z-scores below approximately -2 indicate underweight, values between -2 and +1 generally indicate normal weight, values above +1 indicate overweight, and values above +2 indicate obesity.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Self-Reported Physical Activity (Physical Activity Questionnaire for Children PAQ-C)
Self-reported physical activity will be assessed using the Physical Activity Questionnaire for Children (PAQ-C) aged 6-14 years. Scores range from 1 to 5, with higher scores indicating higher levels of physical activity.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Self-Reported Physical Activity (Physical Activity Questionnaire for Adolescents PAQ-A)
Self-reported physical activity will be assessed using the Physical Activity Questionnaire for Adolescents (PAQ-A) aged 14-17 years. Scores range from 1 to 5, with higher scores indicating higher levels of physical activity.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Fecal Calprotectin
Fecal calprotectin concentration will be measured from stool samples as a biomarker of intestinal inflammation. Results will be expressed in micrograms per gram of stool (µg/g). Higher values indicate greater intestinal inflammation. In clinical practice, fecal calprotectin levels below approximately 50 µg/g are generally considered within the normal range, while levels above 200 µg/g are commonly associated with active intestinal inflammation in inflammatory bowel disease.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
C-Reactive Protein (CRP)
Serum C-reactive protein (CRP) concentration will be measured from blood samples as a marker of systemic inflammation. Results will be expressed in milligrams per liter (mg/L), with higher values indicating greater systemic inflammation. In clinical practice, CRP concentrations below approximately 3 mg/L are generally considered within the normal range, whereas higher levels may indicate the presence of systemic inflammation. In patients with inflammatory bowel disease, elevated CRP levels are commonly associated with active inflammatory disease.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Disease Activity (Pediatric Crohn's Disease Activity Index PCDAI)
Clinical disease activity will be assessed using validated pediatric indices. Crohn's disease activity will be measured using the Pediatric Crohn's Disease Activity Index (PCDAI; range 0-100, higher scores indicate more severe disease activity).
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Disease Activity (Pediatric Ulcerative Colitis Activity Index PUCAI)
Clinical disease activity will be assessed using validated pediatric indices. Ulcerative colitis activity will be measured using the Pediatric Ulcerative Colitis Activity Index (PUCAI; range 0-85, higher scores indicate more severe disease activity).
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Health-Related Quality of Life (IMPACT-III)
Health-related quality of life will be assessed using the Inflammatory Bowel Disease Questionnaire for Children (IMPACT-III). The questionnaire includes multiple domains related to emotional functioning, social functioning, and disease-related concerns. Total scores range from 35 to 175, with higher scores indicating better health-related quality of life.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Fatigue (Pediatric Quality of Life Inventory Multidimensional Fatigue Scale)
Fatigue will be assessed using the Pediatric Quality of Life Inventory (PedsQL) Multidimensional Fatigue Scale, a validated questionnaire designed to measure fatigue symptoms in children and adolescents. Scores range from 0 to 100, with higher scores indicating lower levels of fatigue and better functioning.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Executive Function (BENCI Neuropsychological Battery)
Executive functions will be assessed using the computerized BENCI neuropsychological battery administered on an iPad. The battery evaluates cognitive domains including attention, inhibition, working memory, and cognitive flexibility. Standardized scores will be used to quantify cognitive performance, with higher scores indicating better cognitive functioning.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Attention-Deficit/Hyperactivity Symptoms (ADHD Rating Scale)
Symptoms of attention-deficit/hyperactivity disorder will be assessed using the ADHD Rating Scale, a standardized questionnaire evaluating inattentive and hyperactive-impulsive symptoms in children and adolescents. Total scores range from 0 to 54, with higher scores indicating greater severity of ADHD symptoms.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Anxiety Symptoms (Revised Children's Anxiety and Depression Scale)
Anxiety symptoms will be assessed using the Revised Children's Anxiety and Depression Scale (RCADS). The questionnaire evaluates several domains of anxiety symptoms in children and adolescents. Total scores vary depending on the subscale used, with higher scores indicating greater anxiety symptom severity.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Academic Performance (School Grades)
Academic performance will be evaluated using school grades obtained from school reports. Grades will be analyzed according to the national grading scale used in the participant's educational system, with scores ranging from 0 to 10 and higher values indicating better academic performance.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Mediterranean Diet Adherence (KIDMED Index)
Diet quality will be assessed using the Mediterranean Diet Quality Index for Children and Adolescents (KIDMED). Scores range from -4 to 12, with higher scores indicating better adherence to the Mediterranean diet.
Measured: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Mar 2026
- Study start1 Apr 2026
- Primary completion1 Nov 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Universidad Complutense de Madrid
- Sponsor type
- University, hospital or other
- Collaborators
- Hospital Infantil Universitario Niño Jesús, Madrid, Spain, Universidad Rey Juan Carlos
- Responsible party
- Principal investigator, Carlos Martín Martínez, Universidad Rey Juan Carlos
- Investigators
- Carlos Martín-Martínez, PhD, Principal investigator, Universidad Rey Juan CarlosPaula Sánchez-Llorente, Study chair, Hospital Infantil Universitario Niño JesúsLaura Palomino, Study chair, Hospital Infantil Universitario Niño JesúsRosa Ana Muñoz-Codoceo, PhD, Study chair, Hospital Infantil Universitario Niño JesúsMarta Velasco Rodríguez-Belvís, PhD, Study chair, Hospital Infantil Universitario Niño Jesús
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07484620
- Sponsor's protocol ID
- R-0006/26
- Acronym
- PAFIT-IBD
- Status last verified
- Mar 2026
- First submitted
- 10 Mar 2026
- Last updated
- 3 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Physical Activity and Physical Fitness on Inflammation, Clinical Outcomes, and Quality of Life in Pediatric Inflammatory Bowel Disease
- ClinicalTrials.gov ID
- NCT07484620
- Acronym / sponsor ID
- PAFIT-IBD / R-0006/26
- Keywords
- Pediatric Inflammatory Bowel Disease, Health-Related Quality of Life, Fecal Calprotectin, Physical Fitness, Cardiorespiratory Fitness, Accelerometry, Cognitive Function, Disease Activity
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Universidad Complutense de MadridUniversity, hospital or other
- Collaborators
- Hospital Infantil Universitario Niño Jesús, Madrid, Spain, Universidad Rey Juan Carlos
- Study start
- 1 Apr 2026 (actual)
- Primary completion
- 1 Nov 2026 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 20 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pediatric inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic condition associated not only with intestinal inflammation but also with reduced physical fitness, fatigue, impaired quality of life, and psychosocial difficulties. Although physical activity and physical fitness are recognized as important determinants of health in the general pediatric population, their role as modifiable prognostic factors in children and adolescents with IBD remains insufficiently studied, particularly using objective measures and longitudinal designs in hospital settings.
The present hospital-based study aims to investigate the effects of physical activity and physical fitness on inflammation, clinical outcomes, and quality of life in children and adolescents with IBD. The project comprises three phases: (1) an observational cross-sectional and longitudinal assessment, (2) a randomized controlled trial (RCT) evaluating a structured physical activity intervention, and (3) a medium-term follow-up at 6-12 months.
Physical activity will be assessed objectively using accelerometry and subjectively using validated questionnaires. Physical fitness will be evaluated with the ALPHA fitness battery adapted to the hospital setting, with cardiorespiratory fitness assessed by the 20-meter shuttle run test as the primary outcome of the RCT. Clinical outcomes will include objective inflammatory markers (fecal calprotectin and C-reactive protein), disease activity indices (PCDAI or PUCAI), musculoskeletal health, fatigue, cognitive functioning, and health-related quality of life. Nutritional status and dietary quality will also be assessed, and selected biological markers will be analyzed in a subsample.
The RCT will examine whether a 12-week supervised physical activity program improves cardiorespiratory fitness compared with usual care, and whether changes in fitness are accompanied by improvements in inflammatory burden and patient-reported outcomes. Longitudinal analyses will explore the sustainability of these effects over time.
This study will provide comprehensive, objective evidence on the role of physical activity and physical fitness as modifiable factors in pediatric IBD. The results are expected to inform clinical practice, support the integration of structured physical activity into multidisciplinary care, and contribute high-quality data for publication in international peer-reviewed journals.
Detailed description
Pediatric inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic condition frequently diagnosed during childhood and adolescence. In addition to persistent intestinal inflammation, pediatric IBD is associated with reduced physical activity levels, impaired physical fitness, fatigue, musculoskeletal complaints, cognitive and psychosocial difficulties, and diminished health-related quality of life. Despite advances in pharmacological treatment, many children and adolescents continue to experience functional limitations that are not fully addressed by standard medical care.
Physical activity and physical fitness are modifiable lifestyle factors with well-established benefits in healthy pediatric populations, including anti-inflammatory effects, improved cardiorespiratory and muscular fitness, and better mental health and quality of life. However, in pediatric IBD, evidence remains limited, particularly from studies using objective measurements of physical activity and fitness, randomized controlled designs, and longitudinal follow-up in hospital-based settings. Furthermore, the relationships between physical activity, physical fitness, inflammation, clinical outcomes, and quality of life have not been comprehensively examined within a single integrated study framework.
This hospital-based study aims to evaluate the role of physical activity and physical fitness as modifiable factors influencing inflammation, clinical outcomes, and quality of life in children and adolescents with IBD. The study is conducted in three sequential phases: (1) an observational cross-sectional and longitudinal assessment, (2) a randomized controlled trial (RCT) of a structured physical activity intervention, and (3) a medium-term follow-up at 6 to 12 months.
In the observational phase, participants aged 8 to 17 years with a confirmed diagnosis of Crohn's disease or ulcerative colitis will undergo comprehensive baseline assessments. Physical activity will be measured objectively using accelerometry over seven consecutive days and supplemented by validated questionnaires. Physical fitness will be assessed using the ALPHA fitness battery adapted to the hospital environment, including cardiorespiratory fitness measured by the 20-meter shuttle run test, muscular strength, agility, and body composition. Clinical outcomes will include objective inflammatory markers (fecal calprotectin and C-reactive protein), disease activity indices (PCDAI or PUCAI), musculoskeletal health, fatigue, cognitive functioning, and health-related quality of life. Nutritional status and dietary quality will also be evaluated, and selected biological markers will be analyzed in a subsample.
In the interventional phase, eligible participants will be randomized to either a 12-week structured physical activity program or usual care. The intervention consists of supervised, age-appropriate exercise sessions combining aerobic and strength-based activities, tailored to participants' clinical status and functional capacity. The primary outcome of the RCT is the change in cardiorespiratory fitness, assessed by the number of laps completed in the 20-meter shuttle run test. Secondary outcomes include changes in inflammatory markers, disease activity indices, physical fitness components, fatigue, cognitive performance, nutritional status, and quality of life.
The follow-up phase will assess the sustainability of changes in physical activity, physical fitness, inflammation, and clinical outcomes at 6 to 12 months after baseline assessment or completion of the intervention. Longitudinal analyses will examine whether baseline and intervention-induced changes in physical activity and physical fitness predict medium-term clinical and patient-reported outcomes.
All questionnaires, cognitive assessments, and consent procedures will be administered electronically using secure institutional platforms. Data will be collected and stored in a pseudonymized manner in accordance with applicable data protection regulations.
This study is designed to provide high-quality, objective evidence on the clinical relevance of physical activity and physical fitness in pediatric IBD. By integrating functional, inflammatory, and patient-centered outcomes, the findings are expected to inform multidisciplinary care strategies and support the incorporation of structured physical activity into routine clinical management for children and adolescents with IBD.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Physical Activity Intervention | Experimental | Other: Physical Activity InterventionParticipants will take part in a structured physical activity program lasting 12 weeks. The intervention consists of supervised, age-appropriate exercise sessions combining aerobic and strength-based activities, adapted to each participant's clinical status and functional capacity. All participants receive the same intervention and serve as their own control through pre- and post-intervention assessments. |
Who may qualify
- Ages
- 6 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (6 listed)
- Children and adolescents aged 6 to 17 years
- Confirmed diagnosis of Crohn's disease or ulcerative colitis
- Clinical remission or mild-to-moderate disease activity
- Medical clearance to participate in physical activity
- Ability to complete study assessments and follow-up procedures
Key exclusion criteria (6 listed)
- Severe disease activity or acute flare requiring hospitalization
- Medical contraindications to exercise (e.g., severe cardiopulmonary disease, uncontrolled anemia, significant musculoskeletal conditions)
- Major surgery within the previous 3 months
- Participation in another interventional clinical trial
- Cognitive or behavioral conditions preventing participation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Physical Activity InterventionParticipants will complete a 12-week structured physical activity program consisting of 2-3 supervised sessions per week combining moderate-intensity aerobic exercise and muscle-strengthening activities. The program is age-appropriate, individualized to clinical status and fitness level, and delivered under professional supervision. | Other | Physical Activity Intervention |
Primary outcome
Cardiorespiratory fitness assessed by the 20-meter shuttle run test (20mSRT)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Cardiorespiratory fitness will be assessed using the ALPHA 20-meter shuttle run test (20mSRT). Participants run back and forth between two lines 20 meters apart at increasing speeds guided by audio signals. The outcome is the number of laps completed before exhaustion. Higher values indicate better cardiorespiratory fitness.
Handgrip strength
Time frame: Baseline (Week 0), post-intervention (Week 12) and follow-up (6-12 months)
Upper-limb muscular strength will be assessed using handgrip dynamometry. Participants perform maximal voluntary contractions using a calibrated handgrip dynamometer. The outcome will be expressed in kilograms (kg), with higher values indicating greater muscular strength.
Standing Long Jump
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Lower-body muscular power will be assessed using the standing long jump test. Participants jump forward as far as possible from a standing position. The outcome will be recorded as the distance jumped in centimeters (cm), with greater distances indicating greater muscular power.
19 secondary outcomes
Speed and Agility (4 × 10 m Shuttle Run Test)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Moderate-to-Vigorous Physical Activity (MVPA)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Total Sedentary Time
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Lean Body Mass
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Body Fat Percentage
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Body Mass Index (BMI) z-Score
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Self-Reported Physical Activity (Physical Activity Questionnaire for Children PAQ-C)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Self-Reported Physical Activity (Physical Activity Questionnaire for Adolescents PAQ-A)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Fecal Calprotectin
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
C-Reactive Protein (CRP)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Disease Activity (Pediatric Crohn's Disease Activity Index PCDAI)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Disease Activity (Pediatric Ulcerative Colitis Activity Index PUCAI)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Health-Related Quality of Life (IMPACT-III)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Fatigue (Pediatric Quality of Life Inventory Multidimensional Fatigue Scale)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Executive Function (BENCI Neuropsychological Battery)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Attention-Deficit/Hyperactivity Symptoms (ADHD Rating Scale)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Anxiety Symptoms (Revised Children's Anxiety and Depression Scale)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Academic Performance (School Grades)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Mediterranean Diet Adherence (KIDMED Index)
Time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Not yet recruitingObservational study
Efficacy of Different Biological Treatments in Patients With Inflammatory Bowel Disease After One Year of Treatment in Upper Egypt
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Enrolling by invitation
Effectiveness of Health Education as a Nursing Intervention in Improving Quality of Life and Reducing Symptoms of Anxiety and Depression in Ostomy Patients Following Digestive Surgery: A Quasi-Experimental Study.
Colon Cancer, Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Not yet recruitingObservational study
Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China
Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carlos Martín-Martínez, PhD principal investigator
Universidad Rey Juan Carlos
Paula Sánchez-Llorente study chair
Hospital Infantil Universitario Niño Jesús
Laura Palomino study chair
Hospital Infantil Universitario Niño Jesús
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Physical Activity Intervention in people with Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) and Inflamatory Bowel Disease, run by Universidad Complutense de Madrid at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cardiorespiratory fitness assessed by the 20-meter shuttle run test (20mSRT) (time frame: Baseline (Week 0), post-intervention (Week 12), and follow-up (6-12 months)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026; AzTrials last refreshed its copy on 26 Oct 2026.